Sign in
CompletedNo phase

Diagnostic and Prognostic Roles of Procalcitonin and Highly Sensitive C-Reactive Protein in Early Detection of Burn Sepsis

Key facts

Who runs it
Mansoura University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
1 Sept 2025
Ended
1 Jul 2026
Type of study
Observational
Treatments tested
  • Measurement of Procalcitonin level
  • Measurement of c-reactive protein level
Record updated
27 August 2026

Who can take part

Age
3 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Age from 3 years to 65 years
  • Both sexes
  • Patients with major burn (2nd and 3rd degrees of burn)

Who cannot take part

  • Patients with uncompensated chronic disease e.g. hepatic, renal
  • Patients with unrealistic expectations
  • Patients with inhalational burn injury
  • Patients with mental or psychological troubles affecting the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aimed to evaluate the value of procalcitonin and highly sensitive c-reactive protein as biomarkers for early detection of sepsis in patients with major burns.

The group in the trial

  • Study group

    Patients with major burn (2nd and 3rd degrees of burn)

    Treatment: Measurement of Procalcitonin level and Measurement of c-reactive protein level

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
27 August 2026